Idioma:

Human Immunodeficiency Virus Type 1 Mutations Selected in Patients Failing Efavirenz Combination Therapy

BACHELER, L. T ; ANTON, E. D ; BECKER, M. F ; LASUT, A. L ; GEORGE, H. J ; SPALDING, D. R ; HOLLIS, G ; ABREMSKI, K ; KUDISH, P ; BAKER, D ; BUNVILLE, J ; KRAKOWSKI, K ; BOLLING, L ; AUJAY, M ; WANG, X. V ; ELLIS, D

Antimicrobial Agents and Chemotherapy, 2000-09, Vol.44 (9), p.2475-2484 [Periódico revisado por pares]

Washington, DC: American Society for Microbiology

Texto completo disponível

Citações Citado por

Enviar para

Título:
Human Immunodeficiency Virus Type 1 Mutations Selected in Patients Failing Efavirenz Combination Therapy
Autor: BACHELER, L. T ; ANTON, E. D ; BECKER, M. F ; LASUT, A. L ; GEORGE, H. J ; SPALDING, D. R ; HOLLIS, G ; ABREMSKI, K ; KUDISH, P ; BAKER, D ; BUNVILLE, J ; KRAKOWSKI, K ; BOLLING, L ; AUJAY, M ; WANG, X. V ; ELLIS, D
Assuntos: AIDS/HIV ; Anti-HIV Agents ; Anti-HIV Agents - pharmacology ; Anti-HIV Agents - therapeutic use ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral Agents ; Bacteriology ; Benzoxazines ; Biological and medical sciences ; Clinical Trials, Phase II as Topic ; Drug Resistance, Microbial ; Drug Therapy, Combination ; Efavirenz ; Fundamental and applied biological sciences. Psychology ; Genetics ; HIV Infections ; HIV Infections - drug therapy ; HIV Infections - virology ; HIV Protease - genetics ; HIV Reverse Transcriptase - genetics ; HIV-1 ; HIV-1 - drug effects ; HIV-1 - enzymology ; HIV-1 - genetics ; Human immunodeficiency virus 1 ; Humans ; Medical sciences ; Microbiology ; Molecular Sequence Data ; Mutation ; Oxazines ; Oxazines - pharmacology ; Oxazines - therapeutic use ; Pharmacology. Drug treatments ; Selection, Genetic ; Treatment Failure
É parte de: Antimicrobial Agents and Chemotherapy, 2000-09, Vol.44 (9), p.2475-2484
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Corresponding author. Mailing address: DuPont Pharmaceuticals Company, E336/36B Experimental Station, Wilmington, DE 19880-0336. Phone: (302) 695-4278. Fax: (302) 695-9466. E-mail: lee.bacheler@dupontpharma.com.
Descrição: Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology. For an alternate route to AAC .asm.org, visit: AAC
Editor: Washington, DC: American Society for Microbiology
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Human Immunodeficiency Virus Type 1 Mutations Selected in Patients Failing Efavirenz Combination Therapy

BACHELER, L. T ; ANTON, E. D ; BECKER, M. F ; LASUT, A. L ; GEORGE, H. J ; SPALDING, D. R ; HOLLIS, G ; ABREMSKI, K ; KUDISH, P ; BAKER, D ; BUNVILLE, J ; KRAKOWSKI, K ; BOLLING, L ; AUJAY, M ; WANG, X. V ; ELLIS, D

Washington, DC: American Society for Microbiology

Buscando em bases de dados remotas. Favor aguardar.